17 retos para los sistemas sanitarios de latinoamérica: ¿qué puede aprenderse de la experiencia europea? challenges to latin-american health systems: what can be learned from the european experience?

18 effects of comprehensive smoke-free legislation in europe efectos de la legislación antitabaco en europa

19 prioridades y desafíos en la cooperación ambiental entre europa y américa latina: un comentario

20 europe and the atlantic world. a historiographic summary

21 la figura de diego abad de santillán como nexo entre el anarquismos argentino, europeo y latinoamericano, 1920-1930

22 foreword | presentación

23 intercultural peace. europe, seeking an identity

24 selenio en suero y plasma: epidemiología y valores de referencia selenium in serum and plasma: epidemiology and reference values

25 divulgación: la creación de la unión europea y sus principales instituciones

26 SA REPOSITORYO NG MGA KULTURANG MATERYAL: PERSONAL NA TALA NG PAGLALAKBAY UKOL SA MGA MUSEO SA IBAYONG DAGAT NG ASYA-PASIPIKO AT EUROPA

27 The gene for hereditary sensory neuropathy type I (HSN-I) maps to chromosome 9q22.1-q22.3.

28 Phytochemical profile, mineral content, and antioxidant activity of Olea europaea L. cv. Cornezuelo table olives. Influence of in vitro simulated gastrointestinal digestion

29 Nrf2/HO-1 signaling pathway participated in the protection of hydrogen sulfide on neuropathic pain in rats.

30 Phenolic and Antioxidant Analysis of Olive Leaves Extracts (<i>Olea europaea</i> L.) Obtained by High Voltage Electrical Discharges (HVED)

31 Traditional Uses, Phytochemistry, and Pharmacology of Olea europaea (Olive)

32 Phytochemical profile, mineral content, and antioxidant activity of Olea europaea L. cv. Cornezuelo table olives. Influence of in vitro simulated gastrointestinal digestion

33 Screening of the antioxidant properties of olive (Olea europaea) leaf extract by titanium based reduced graphene oxide electrode

34 Feasible production of biomass and natural antioxidants through callus cultures in response to varying light intensities in olive (Olea europaea. L) cult. Arbosana

35 Genotype-related differences in the phenolic compound profile and antioxidant activity of extracts from olive (Olea europaea L.) leaves

36 An integrated perspective on diabetic, alcoholic, and drug-induced neuropathy, etiology, and treatment in the US

37 mTOR signaling in the neuropathophysiology of depression: current evidence

38 An integrated perspective on diabetic, alcoholic, and drug-induced neuropathy, etiology, and treatment in the US

39 mTOR signaling in the neuropathophysiology of depression: current evidence

40 The impact of demographic and clinical characteristics on diabetic painful neuropathy.

41 Huangqi Guizhi Wuwu decoction for diabetic peripheral neuropathy: Protocol for a systematic review.

42 The effect of TLR4/MyD88 inhibition by salvianolic acid B on neuropathic pain following spinal cord injury in mice.

43 DF2726A, a new IL-8 signalling inhibitor, is able to counteract chemotherapy-induced neuropathic pain

44 Role of PAF receptor in proinflammatory cytokine expression in the dorsal root ganglion and tactile allodynia in a rodent model of neuropathic pain.

45 Relief of Neuropathic Pain After Spinal Cord Stimulator Implantation in a Patient With Idiopathic Thoracic Transverse Myelitis: A Case Report.

46 Clinical outcome and ultrasonographic evaluation of treatment using polyglycolic acid-collagen tube for chronic neuropathic pain after peripheral nerve injury.

47 Microglia-neuron interactions in the models of neuropathic pain.

48 The multifunctional peptide DN-9 produced peripherally acting antinociception in inflammatory and neuropathic pain via mu and kappa opioid receptors.

49 Pathological Observation of Blood Stasis Syndrome in Non-diabetic Peripheral Neuropathies: A Retrospective Analysis Based on Nerve Biopsy.

50 Pathological Mechanisms and Therapeutic Targets for Trigeminal Neuropathic Pain.

51 Retroperitoneal schwannoma associated with neuropathic pain and electromyographic and nerve conduction abnormalities: A case report

52 Layer- and subregion-specific electrophysiological and morphological changes of the medial prefrontal cortex in a mouse model of neuropathic pain

53 Effect of NIR laser therapy by MLS-MiS source against neuropathic pain in rats: in vivo and ex vivo analysis

54 Retraction Note: Ultra-diluted Toxicodendron pubescens attenuates pro-inflammatory cytokines and ROS- mediated neuropathic pain in rats (Scientific Reports, (2018), 8, 1, (13562), 10.1038/s41598-018-31971-9)

55 Effects of 1,8-cineole on neuropathic pain mediated by P2X2 receptor in the spinal cord dorsal horn

56 CB2 receptor deletion on myeloid cells enhanced mechanical allodynia in a mouse model of neuropathic pain

57 Facilitation of neuropathic pain by the NPY Y1 receptor-expressing subpopulation of excitatory interneurons in the dorsal horn

58 Silencing of spinal Trpv1 attenuates neuropathic pain in rats by inhibiting CAMKII expression and ERK2 phosphorylation

59 Key role of gut microbiota in anhedonia-like phenotype in rodents with neuropathic pain

60 Preventive effects of progesterone against neuropathic pain responses in a rat model of chronic constriction injury

61 Identification of novel therapeutic targets for neuropathic pain based on gene expression patterns

62 Acute antinociceptive effect of fish oil or its major compounds, eicosapentaenoic and docosahexaenoic acids on diabetic neuropathic pain depends on opioid system activation

63 Inhibition of cytochrome P450c17 reduces spinal astrocyte activation in a mouse model of neuropathic pain via regulation of p38 MAPK phosphorylation

64 Glycine transporter inhibitors: A new avenue for managing neuropathic pain

65 Antinociceptive effect of isoorientin against neuropathic pain induced by the chronic constriction injury of the sciatic nerve in mice

66 Assessment of anti-nociceptive effect of allopurinol in a neuropathic pain model

67 Role of spinal glial cells in excitability of wide dynamic range neurons and the development of neuropathic pain with the L5 spinal nerve transection in the rats: Behavioral and electrophysiological study

68 Upregulation of tumor necrosis factor-alpha in the anterior cingulate cortex contributes to neuropathic pain and pain-associated aversion

69 Identification of the First Synthetic Allosteric Modulator of the CB <inf>2</inf> Receptors and Evidence of Its Efficacy for Neuropathic Pain Relief

70 Effect of single and repeated administration of amitriptyline on neuropathic pain model in rats: Focus on glutamatergic and upstream nitrergic systems

71 Dysregulation of p53 and Parkin Induce Mitochondrial Dysfunction and Leads to the Diabetic Neuropathic Pain

72 Correction to: lncRNA NONRATT021972 siRNA Decreases Diabetic Neuropathic Pain Mediated by the P2X3 Receptor in Dorsal Root Ganglia (Molecular Neurobiology, (2017), 54, 1, (511-523), 10.1007/s12035-015-9632-1)

73 Neoline is the active ingredient of processed aconite root against murine peripheral neuropathic pain model, and its pharmacokinetics in rats

74 Electroacupuncture decreases Netrin-1-induced myelinated afferent fiber sprouting and neuropathic pain through μ-opioid receptors

75 Pharmacological Regulation of Neuropathic Pain Driven by Inflammatory Macrophages

76 MAPK signaling downstream to TLR4 contributes to paclitaxel-induced peripheral neuropathy.

77 Toll-like receptor 4 signaling contributes to Paclitaxel-induced peripheral neuropathy.

78 Randomized, controlled crossover study of IVIg for demyelinating polyneuropathy and diabetes.

79 Readers response to "Sequential nonarteritic anterior ischemic optic neuropathy in patient on chronic hemodialysis".

80 Anti-pan-neurofascin IgG3 as a marker of fulminant autoimmune neuropathy.

81 Acute-onset chronic inflammatory demyelinating polyneuropathy with anti-neurofascin-155 antibodies and bilateral facial nerve enhancement.

82 Short-term strength and balance training does not improve quality of life but improves functional status in individuals with diabetic peripheral neuropathy: a randomised controlled trial.

83 Epidemiology of Peripheral Neuropathy and Lower Extremity Disease in Diabetes.

84 Management of diabetic neuropathic foot and ankle malunions and nonunions

85 Interleukin-6 and hs-CRP as Early Diagnostic Biomarkers for Obesity-Related Peripheral Polyneuropathy in Non-Diabetic Patients.

86 Accuracy of machine learning for differentiation between optic neuropathies and pseudopapilledema

87 Endocrine exophthalmus and optic neuropathy. Results of immuno suppressive therapeutics

88 Highly selective microglial uptake of ceria-zirconia nanoparticles for enhanced analgesic treatment of neuropathic pain.

89 Nerve decompression and neuropathy complications in diabetes: Are attitudes discordant with evidence?

90 Clinical Findings and Electrodiagnostic Testing in Ulnar Neuropathy at the Elbow and Differences According to Site and Type of Nerve Damage.

91 Salvage procedures in lower-extremity trauma in a child with hereditary motor and sensory neuropathy type I: a case report

92 Validation of the Serbian version of inflammatory Rasch-built overall disability scale in patients with chronic inflammatory demyelinating polyradiculoneuropathy.

93 Food derived respiratory complex I inhibitors modify the effect of Leber hereditary optic neuropathy mutations.

94 Clinical significance of lower-lobe interstitial lung disease on high-resolution computed tomography in patients with idiopathic pleuroparenchymal fibroelastosis.

95 Differences Between Patients With Idiopathic Pleuroparenchymal Fibroelastosis and Those With Other Types of Idiopathic Interstitial Pneumonia in Candidates for Lung Transplants

96 Usual Interstitial Pneumonia Pattern in the Lower Lung Lobes as a Prognostic Factor in Idiopathic Pleuroparenchymal Fibroelastosis

97 A bioactive extract from Olea europaea protects newly weaned beef heifers against experimentally induced chronic inflammation1.

98 A Cost-Effectiveness Analysis Of Pregabalin For The Treatment Of Patients With Chronic Cervical Pain With A Neuropathic Component In Japan.

99 Small fiber neuropathy in coeliac disease and gluten sensitivity

100 Pregabalin and gabapentin in neuropathic pain management after spinal cord injury: a systematic review and meta-analysis.

101 Peripheral effects of morphine and expression of μ-opioid receptors in the dorsal root ganglia during neuropathic pain: nitric oxide signaling

Keyword Connections

Journals

Research Groups

Bibliographies